(Q54071584)
Statements
Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure (English)
Hochhaus A
1 reference
Gratwohl A
Hehlmann R
Kolb HJ
Hasford J
Heimpel H
Siegert W
Finke J
Holler E
Berger U
Pfirrmann M
Muth A
Zander A
Fauser AA
Heyll A
Nerl C
Hossfeld DK
Löffler H
Pralle H
Queisser W
Tobler A